Balchem Current Valuation vs. Revenue

BCPC Stock  USD 179.58  1.59  0.89%   
Taking into consideration Balchem's profitability measurements, Balchem's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Balchem's ability to earn profits and add value for shareholders. At present, Balchem's EV To Sales is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 5.44, whereas Days Sales Outstanding is forecasted to decline to 37.94. At present, Balchem's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's Income Before Tax is expected to grow to about 144.1 M, whereas Total Other Income Expense Net is projected to grow to (20.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.440.3275
Significantly Up
Very volatile
Net Profit Margin0.07410.1177
Way Down
Very volatile
Operating Profit Margin0.110.1726
Way Down
Very volatile
Pretax Profit Margin0.10.1488
Way Down
Pretty Stable
Return On Assets0.110.068
Way Up
Slightly volatile
Return On Equity0.170.103
Way Up
Slightly volatile
For Balchem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Balchem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Balchem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Balchem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Balchem over time as well as its relative position and ranking within its peers.
  

Balchem's Revenue Breakdown by Earning Segment

Check out Trending Equities.
For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Dividend Share
0.79
Earnings Share
3.74
Revenue Per Share
29.208
Quarterly Revenue Growth
0.043
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Balchem Revenue vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Balchem's current stock value. Our valuation model uses many indicators to compare Balchem value to that of its competitors to determine the firm's financial worth.
Balchem is rated fourth in current valuation category among its peers. It is rated below average in revenue category among its peers totaling about  0.15  of Revenue per Current Valuation. The ratio of Current Valuation to Revenue for Balchem is roughly  6.57 . At present, Balchem's Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balchem's earnings, one of the primary drivers of an investment's value.

Balchem's Earnings Breakdown by Geography

Balchem Current Valuation vs. Competition

Balchem is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Materials industry is currently estimated at about 49.96 Billion. Balchem retains roughly 6.06 Billion in current valuation claiming about 12% of all equities under Materials industry.

Balchem Revenue vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Balchem

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
6.06 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Balchem

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
922.44 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Balchem Revenue vs Competition

Balchem is rated below average in revenue category among its peers. Market size based on revenue of Materials industry is currently estimated at about 23.69 Billion. Balchem holds roughly 922.44 Million in revenue claiming about 4% of all equities under Materials industry.

Balchem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Balchem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Balchem will eventually generate negative long term returns. The profitability progress is the general direction of Balchem's change in net profit over the period of time. It can combine multiple indicators of Balchem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income8.7 M9.1 M
Operating Income159.2 M167.2 M
Income Before Tax137.3 M144.1 M
Total Other Income Expense Net-21.9 M-20.8 M
Net Income108.5 M114 M
Income Tax Expense28.7 M30.2 M
Net Income Applicable To Common Shares121.2 M127.2 M
Net Income From Continuing Ops108.5 M79.1 M
Non Operating Income Net Other-1.1 M-999.5 K
Interest Income6.4 M4.3 M
Net Interest Income-22.6 M-21.5 M
Change To NetincomeM6.3 M
Net Income Per Share 3.38  3.55 
Income Quality 1.69  1.67 
Net Income Per E B T 0.79  0.54 

Balchem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Balchem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Balchem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Balchem's important profitability drivers and their relationship over time.

Use Balchem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Balchem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balchem will appreciate offsetting losses from the drop in the long position's value.

Balchem Pair Trading

Balchem Pair Trading Analysis

The ability to find closely correlated positions to Balchem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Balchem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Balchem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Balchem to buy it.
The correlation of Balchem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Balchem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Balchem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Balchem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Balchem position

In addition to having Balchem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Funds Thematic Idea Now

Healthcare Funds
Healthcare Funds Theme
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:
Check out Trending Equities.
For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
To fully project Balchem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Balchem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Balchem's income statement, its balance sheet, and the statement of cash flows.
Potential Balchem investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Balchem investors may work on each financial statement separately, they are all related. The changes in Balchem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Balchem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.